Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy
Thoracic Cancer · 2025
DOI: 10.1111/1759-7714.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Lucia Mangone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Pneumonectomy, Lung Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Although smoking cessation remains the most effective preventive measure against lung cancer, the implementation of low‐dose computed tomography screening has facilitated early tumor detection, increasing the need for less invasive surgical approaches. This study evaluated the efficacy of segmentectomy vs. lobectomy for early‐stage non‐small cell lung cancer (NSCLC) in northern Italy. Material and Methods The analysis included 200 patients with stage I NSCLC, selected from a cancer registry. Of these, 100 underwent lobectomy and 100 underwent segmentectomy. We calculated loco‐regional and distant recurrences, overall survival, and disease‐free survival (DFS).
Results
Over a median follow‐up of 6.3 years, segmentectomy was associated with a lower recurrence rate (28%) compared to lobectomy (35%) and a lower incidence of distant metastases (39.6% vs. 60.4%). Multivariable analysis showed a greater risk of recurrence in patients undergoing lobectomy [OR 1.32; 95% CI: 0.71–2.45] and in females [OR 1.69; 95% CI: 0.89–3.18], while a decreased risk was observed among elderly patients over 70 years [OR 0.72; 95% CI: 0.39–1.32] and those with adenocarcinoma histology [OR 0.82; 95% CI: 0.41–1.64]. Five‐year survival was higher in the segmentectomy group (67%; 95% CI: 57–76) compared to the lobectomy group (55%; 95% CI: 45–65); a similar result was observed for DFS: 59% (95% CI: 48–68) versus 47% (95% CI 37–57). The risk of death appeared lower in the segmentectomy group [HR 0.85; 95% CI: 0.59–1.22].
Discussion
The outcomes appear to favor segmentectomy, as previously demonstrated in clinical trials. The observed effects are less pronounced, due to the absence of patient selection in this real‐world setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Thoracic Surgery Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Scientific Directorate, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Gruppo Amici Dell'ematologia Foundation-GrADE, Reggio Emilia, Italy.
ORCID-Profile: Lucia Mangone
Zitieren
APA
Mangone, L., Marinelli, F., Bisceglia, I., Bianchi, D., Rapicetta, C., Neri, A., Morabito, F., & Paci, M. (2025). Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70097
Vancouver
Mangone L, Marinelli F, Bisceglia I, Bianchi D, Rapicetta C, Neri A, et al. Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70097
BibTeX
@article{Mangone2025,
author = {Mangone, Lucia and Marinelli, Francesco and Bisceglia, Isabella and Bianchi, Daniel and Rapicetta, Cristian and Neri, Antonino and Morabito, Fortunato and Paci, Massimiliano},
title = {Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy},
journal = {Thoracic Cancer},
year = {2025},
doi = {10.1111/1759-7714.70097}
}
EUVIMED